# Adecoagro S.A. (AGRO) — Financial Analysis

**Exchange:** NYSE  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-06-12  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/AGRO/thesis · /stocks/AGRO/memo

## Financial Snapshot

---
source: coverage-next-full
step: 04
ticker: AGRO
company: Adecoagro S.A.
date: 2026-06-11
---

### Step 04 — Financial Quality & Adversarial Sweep: AGRO (Adecoagro S.A.)

#### 1. Statement Quality Assessment

##### IFRS Accounting Considerations

AGRO files under IFRS (as a Luxembourg-incorporated foreign private issuer), which introduces several non-cash, mark-to-market adjustments that significantly distort reported earnings: [S1]

**IAS 41 — Biological Assets (High Distortion Risk)**
- AGRO must mark standing crops, livestock, and sugarcane to fair value at each reporting date
- These fair value adjustments appear in gross profit and can be $50–200M in any given year
- FY2021: ~$228M positive biological asset FV adjustment (inflated gross margin to 43.1%)
- FY2024: ~$53M negative adjustment (compressed gross margin to 28.6%)
- **Analyst implication:** IFRS gross profit is not comparable year-over-year. Use Adj. EBITDA (which excludes biological FV changes) as the primary profitability metric.

**IAS 29 — Hyperinflationary Accounting (Argentina)**
- Argentina was designated as a hyperinflationary economy in 2018
- AGRO restates its ARS-denominated monetary items for inflation effects
- FY2023: $157.1M one-off finance income from ARS hyperinflationary adjustment (Argentina had ~211% CPI in 2023)
- FY2024: Finance income collapsed to $16.8M as the one-off effect reversed
- **Risk:** Reported net income swings of $100M+ are possible purely from IAS 29 effects, unrelated to operating performance

**IFRS vs. U.S. GAAP Revenue Differences**
- IFRS recognizes "Initial recognition and changes in fair value of biological assets and agricultural produce" directly in revenue-adjacent line items
- Revenue as reported (~$1.52B in FY2024) is relatively clean; distortions are below the revenue line

##### Statement Quality Adjustments

| Item | IFRS Reported | Adjustment | Adjusted |
|------|--------------|-----------|---------|
| Revenue (FY2024) | $1,519M | None | $1,519M |
| Gross Profit (FY2024) | $435M | +$53M (remove negative bio FV) | ~$488M |
| Net Income (FY2024) | $92M | None needed | $92M |
| Net Income (FY2023) | $227M | -$157M (remove IAS 29 one-off) | ~$70M (normalized) |
| Adj. EBITDA (FY2024) | $444M (management) | — | $444M |

**Normalized FY2023 earnings: ~$70M** (vs. reported $227M). The headline 2023 EPS of $2.11 is misleading — normalized EPS was closer to $0.65–0.70.

##### SBC & Dilution Assessment

- SBC in FY2024: $8.1M (0.5% of revenue) — immaterial
- Share count: declining from ~120M (2017) to ~100M (2024) via active buybacks ($66.9M in FY2024)
- December 2025 equity raise: 42M new shares at $7.25/share for Profertil funding — this increased share count by ~40%, materially dilutive. Partially offset by prior buybacks.
- Post-raise shares outstanding: ~135–140M estimated

##### Cash Flow Quality

| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|--------|--------|--------|--------|--------|
| Operating CF | $370M | $435M | $328M | $309M |
| CapEx | -$227M | -$242M | -$262M | -$264M |
| FCF | $143M | $193M | $66M | $44M |
| Dividends | — | — | — | $35M+ |
| Buybacks | — | — | $66.9M | — |

FCF deteriorated sharply in FY2024–FY2025 as capex accelerated (mill expansion, new equipment) and Profertil integration costs emerged. Management guided toward deleveraging to 2.0x net debt/EBITDA by end-2026 from ~3.3x post-acquisition, implying FCF recovery in FY2026+ once capex normalizes.

#### 2. Adversarial Research Sweep

##### Category 1: Short Seller / Negative Reports

No major short-seller reports identified targeting Adecoagro specifically. The stock has garnered modest attention from value-oriented investors given its low P/B ratio (0.93x as of mid-2026). [S2]

However, the following risks identified through press and analyst commentary are effectively "bear cases" in public discourse:

##### Category 2: Tether/Related-Party Risk

**Finding:** The Profertil acquisition involved purchasing 50% of the asset from Best-in-Class Investments, a vehicle controlled by Tether Investments (the same entity that controls AGRO). This is a textbook related-party transaction. [S3]

- Was the $1.1B valuation arm's-length? Profertil had $467M pro-forma EBITDA in FY2025 on a full-year basis. At that EBITDA, the acquisition price implies ~2.4× EV/EBITDA for 100% of Profertil (~$2.2B total EV; AGRO paid ~$1.1B for 50%). Comparable industrial urea plants trade at 5–8× EV/EBITDA globally — suggesting AGRO may have paid below fair market value, which would be favorable to AGRO's minority shareholders if confirmed.
- However, the timing (selling from Tether's other pocket to AGRO which Tether controls) and the discounted $7.25/share equity raise (vs. ~$14/share market price) suggest the economic benefit was structured to favor Tether's cost basis, not AGRO's minority shareholders.
- **J.P. Morgan's Sell rating ($7 PT)** explicitly cited governance concerns around Tether's ownership and the dilutive equity raise structure as key risks. [S2]

##### Category 3: Argentine Country Risk

- Argentina has a history of debt defaults (2001, 2020), capital controls, forced peso conversions, and export-retention policy reversals
- IAS 29 hyperinflationary accounting creates earnings noise
- Milei administration (2023–present) has reduced distortions but risk of policy reversal in mid-term elections (2025) remains
- Los Grobo's December 2024 bankruptcy ($207M debt default) demonstrates the risk of over-leveraged Argentine agricultural operators — a cautionary industry data point [S2]

##### Category 4: Leverage Risk Post-Profertil

- Net debt increased from ~$568M (FY2024) to ~$1.8B+ post-Profertil acquisition
- Net debt/EBITDA: ~3.3× post-acquisition (above AGRO's historical ~1.5–2.5× comfort zone)
- The deleveraging path (to 2.0× by end-2026) depends on: (a) Profertil EBITDA contribution materializing (~$200–250M/year at 50%), (b) SE&E crushing recovery, and (c) FCF improvement
- If urea prices or sugar prices weaken simultaneously, the deleveraging timeline extends and re-financing risk grows

##### Category 5: Environmental & Regulatory

- Sugarcane burning: Brazilian legislation requires gradual reduction of cane burning in harvesting; AGRO's continuous harvest model is largely mechanized (positive)
- Water usage in Brazilian agriculture has become a regulatory focus (limited near-term risk for AGRO)
- No material environmental enforcement actions identified [S2]

##### Category 6: Bitcoin Mining Distraction

- AGRO signed an MOU with Tether to evaluate Bitcoin mining using up to 5% of Mato Grosso do Sul bioelectricity capacity
- At current scale, this would be ~$10–20M revenue opportunity at best — immaterial
- The strategic signaling is concerning: it suggests Tether may redirect capital-allocation decisions toward crypto, not shareholder returns [S3]

#### 3. Financial Quality Verdict

| Dimension | Rating | Notes |
|-----------|--------|-------|
| Revenue quality | B+ | Commodity revenue; clean recognition; IAS 41 distortions below revenue line |
| Earnings quality | C+ | IFRS biological FV + IAS 29 create large noise; Adj. EBITDA is more reliable |
| Cash conversion | B | OCF generally strong; FCF compressed by rising capex cycle; watch post-Profertil normalization |
| Balance sheet | C+ | Significantly levered post-Profertil; ARS-denominated assets create currency risk |
| Governance | C | FPI status = minimal disclosure; Tether related-party acquisition; dilutive equity raise |

**Overall: B-** — Operationally sound commodity business with a clean revenue recognition model, but earnings are meaningfully distorted by IFRS mark-to-market rules, and governance concerns from Tether's controlling position represent a genuine minority shareholder risk.

---

#### Source Index
| Code | Source |
|------|--------|
| [S1] | SEC 20-F FY2022–FY2024; XBRL data; `xbrl/xbrl_summary.md` |
| [S2] | StockAnalysis; consensus; `other/consensus.md`; `other/stockanalysis_summary.md` |
| [S3] | Proxy/governance; insider transactions; `proxy/governance_and_compensation.md` |

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/AGRO/fundamental

## Navigation

- Overview: /stocks/AGRO
- Financials (this page): /stocks/AGRO/financials
- Thesis: /stocks/AGRO/thesis
- Investment Memo: /stocks/AGRO/memo
- Coverage universe: /stocks